|
|
|
|
|
by danso
3907 days ago
|
|
You seem to be missing the part where former employees claim that the company skirted federal regulations by using other machines for the proficiency testing, while using the Edison machines for patient testing. The accuracy of those claims have some relevance to the kind of speculation you hope to make. |
|
Theranos:
(1) takes a much smaller amount of blood, claiming they will use the Edison machine to analyze it
(2)(a) sometimes uses the Edison machine, whose accuracy is disputed
(2)(b) sometimes dilutes the sample to test using a regular machine. The dilution moves normal concentrations outside the range of detection of the machine, so when a 10x dilution has its concentration multiplied by 10, there are huge errors, often causing misdiagnosis
When Theranos receives a proficiency test, they don't receive a small amount of blood. They receive the amount of blood a normal lab receives. These are the only samples that they can run in the manner the standard machines were designed for.
Theranos competes on costing less and taking less blood. The doubts are all around whether you can get accurate results with smaller amounts of blood from a different body part.